960299-06-3 Usage
Uses
Used in Pharmaceutical Research and Development:
4-chloro-6-Methoxy-5-MethylpyriMidine is used as a key intermediate in the synthesis of pharmaceutical drugs. Its unique structure allows for the development of new drug candidates with potential therapeutic applications.
Used in Agrochemical Production:
4-chloro-6-Methoxy-5-MethylpyriMidine is also utilized in the production of agrochemicals, contributing to the development of new pesticides and other agricultural chemicals to improve crop protection and yield.
Used in Organic Synthesis:
4-chloro-6-Methoxy-5-MethylpyriMidine serves as a building block in the synthesis of various heterocyclic compounds, which are important in the creation of complex organic molecules with diverse applications.
Used in Anti-Inflammatory and Anticancer Research:
4-chloro-6-Methoxy-5-MethylpyriMidine has been studied for its potential anti-inflammatory and anticancer properties, making it a valuable compound in the search for new treatments for these conditions.
Used in Research and Industrial Applications:
4-chloro-6-Methoxy-5-MethylpyriMidine is commercially available for research purposes, enabling scientists and researchers to explore its properties and potential uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 960299-06-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,6,0,2,9 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 960299-06:
(8*9)+(7*6)+(6*0)+(5*2)+(4*9)+(3*9)+(2*0)+(1*6)=193
193 % 10 = 3
So 960299-06-3 is a valid CAS Registry Number.
960299-06-3Relevant academic research and scientific papers
QUINOLINE COMPOUNDS AND METHODS OF USE
-
Page/Page column 115, (2008/06/13)
Compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof, are useful for inhibiting receptor tyrosine kinases and for treating hyperproliferative disorders mediated thereby. Methods of using compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. [ Formula I]
